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Enhancement of transforming growth factor-a. synthesis in multicellular
tumour spheroids of A431 squamous carcinoma cells
K.R. Laderoute, B.J. Murphy, S.M. Short, T.D. Grant, A.M. Knapp & R.M. Sutherland
Laboratory ofCell and Molecular Biology, Life Sciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, California 94025, USA.
Summary Multicellular tumour spheroids are cellular aggregates that can be prepared from many types of
tumour cells. These three-dimensional structures provide a model for analysing the effects of cell-cell contact and intercellular microenvironments on phenomena such as autocrine regulation of growth factor synthesis. Autoregulation of the synthesis of transforming growth factor-a (TGF-a) was investigated at the message and protein levels in spheroid and monolayer cultures prepared from the A431 human squamous carcinoma cell line. The epidermal growth factor receptor (EGF-R) of these monolayer A431 cells had an average surface density of 2.2 x 106/cell. Constitutive expression of TGF-a mRNA was an average of 3-fold greater in A431 spheroids than in monolayers, even for densely packed, confluent monolayers. This effect did not depend on hypoxic stress within the spheroids. TGF-a protein sythesis was enhanced in comparison with that in monolayer culture, reaching a value of up to 2-fold greater on a per cell basis. These results are discussed in the context of a TGF-a/EGF-R autocrine loop operating within cells that produce high local concentrations of TGF-a in the three-dimensional architecture of a spheroid.
Transforming growth factor-a (TGF-x), a ligand for the
epidermal growth factor receptor (EGF-R), is produced by
many cell lines obtained from tumours and by some virally
transformed cells (DeLarco & Todaro, 1978; Todaro et al.,
1980; Derynck et al., 1987). The widespread occurrence of
TGF-x expression in neoplastic and transformed cells, coupl-
ed with the presence of its receptor on many of these cells,
led to the hypothesis that this growth factor can contribute
to the development of neoplasia through an autocrine loop
(Sporn & Todaro, 1980). In support of this growth mechan-
ism, TGF-a is known to be induced by an autocrine response
in human keratinocytes and may regulate cell proliferation in
the epidermis (Coffey et al., 1987). Overexpression of the
EGF-R occurs in a variety of human tumours and has been
strongly associated with transformation. These observations
provide further support for the importance of the TGF-a/
EGF-R autocrine loop in human cancer (Xu et al., 1984;
King et al., 1985; Chen et al., 1991).
The EGF group of polypeptide regulatory molecules
includes EGF precursors, TGF-a, amphiregulin, and the
vaccinia virus growth factor precursor (Massague, 1990).
The mature secreted form of TGF-a is a 50-amino-acid
polypeptide cleaved from a 160-amino-acid precursor called
pro-TGF-a that has transmembrane forms. Transmembrane
pro-TGF-x, which can be glycosylated as well as palmi-
toylated, can also be cleaved to produce heterogeneously
glycosylated soluble forms (Massague, 1990). Membrane-
bound pro-TGF-.a has been proposed to possess biologically
relevant cell-cell adhesion and cell-cell receptor activation
properties (Massague, 1990; Brachmann et al., 1989; Wong et
al., 1989). Cell-cell signalling by membrane-bound pro-TGF-
x would be a significant phenomenon in cellular aggregates,
where cells other than those of the outer layer are sur-
rounded by neighbours.
Many types of cancer cells can be cultured as three-dimen-
sional structures, called multicellular spheroids (Sutherland,
1988). Depending on spheroid size, the exposure of inner
cells to diffusible substances such as nutrients and regulatory
molecules can be limited and can lead to the establishment of
different microenvironments within the structure. For exam-
ple, hypoxia (Sutherland, 1988), lowered extracellular pH
(Acker et al., 1987), and glucose gradients (Casiari, 1989)
have been described in spheroids. A more subtle aspect of the
geometry of spheroids involves the contribution of cell-cell
contact to such properties as the response to growth factors.
For example, autoregulation of TGF-a has been found to be
affected by spheroid formation in two adenocarcinomas cell
lines (Theodorescu et al., submitted to Mol. Cell Biol.).
Multicellular spheroids prepared from human squamous
carcinoma cell (SCC) lines are used in our laboratory to
simulate tumour-like microenvironments and effects of cell
contact. In particular, spheroids composed of A431 or CaSki
cells are used to investigate responses to EGF (Kwok &
Sutherland, 1989; 1991) and TGF-a. These cells have very high surface densities of the EGF-R (Cowley et al., 1986;
Yamamoto et al., 1986).
This report is concerned with the importance of cellular
aggregation on TGF- o synthesis and the use of multicellular
spheroids to model the TGF-a/EGF-R autocrine loop in
solid tumours. Enhanced synthesis of the growth factor at
both the message and protein levels is shown. The proximity
of cells having high EGF-R surface densities, together with
elevated local concentrations of TGF- o that are likely to exist
in the confined intercellular spaces in spheroids, is hypo-
thesised to enhance TGF-a expression relative to that in
monolayer cultures.
Materials and methods
Cell culture andspheroidformation
A431 cells were maintained in Dulbecco's Minimum Essential
Medium (DMEM) supplemented with 10% foetal bovine
serum (FBS) (Gibco Laboratories, Grand Island, NY). No
antibiotics were used in the cell culture medium. Cells were
maintained in culture for 10 weeks before a new thaw was
initiated.
Monolayer cultures were prepared at the start of day 1 by plating various suspensions of cells into 100 mm tissue-
culture grade petri dishes (Corning, Corning, NY) containing
10 ml of DMEM/10% FBS and incubating in 5% CO2 at
37°C for 4 days. Two dishes were used for each RNA
extraction. Plating densities for TGF-a protein analyses are
reported in the Results. At a plating density of 2 x I05
cells/dish, the monolayer cultures were growing exponentially
on day 4. To prepare day 4 plateau phase monolayer cul-
tures, 6 x 105 cells/dish were plated.
Correspondence: K. Laderoute, LA 258, SRI International, 333
Ravenswood Avenue, Menlo Park, CA 94025, USA.
Received 14 June 1991 and in revised form 23 September 1991.
'." Macmillan Press Ltd., 1992 Br. J. Cancer (1992), 65, 157-162158 K.R. LADEROUTE et al.
Day 4 spheroids were chosen for these studies because they
attain the maximum size distribution of spheroidal aggregates
of A431 cells that can be prepared on a semisolid medium.
Because day 4 spheroid cultures contain fewer cells/dish than
day 4 monolayer cultures, six dishes of spheroids were har-
vested compared to two dishes of monolayers to ensure that
approximately the same total number of spheroid and mono-
layer cells were lysed on day 4 (typically a mean value of
5 x 10' cells). Suspensions of 1.2 x 106 cells were plated in
10 ml of DMEM/10% FBS on 2% Noble agar (Difco Labor-
atories, Detroit, MI) prepared in 10% DMEM and coated
on 100 mm Lab-Tek petri dishes (Nunc, Inc., Naperville, IL).
Seven dishes were prepared and one dish was used for count-
ing cells on day 4. Estimates of the sizes of randomly selected
spheroids were calculated from the cubic means of ortho-
gonal diameters measured using the eyepiece graticule of a
phase-contrast inverted microscope.
In experiments designed to compare the effect of EGF on
TGF-a message in monolayer and spheroid cultures, recom-
binant murine EGF (Collaborative Research, Inc., Bedford,
MA) was added to monolayer and spheroid cultures to a
final concentration of 10 ng ml1 ' in 10 ml of medium (100 il
of 1,000 ng ml1 stock solution) on day 4. A typical time
course for exposure to EGF was 0 h, 0.25 h, 0.5 h, 1 h and
2 h. Negative controls lacking added EGF were prepared for
the 2 h time points. Each time course was quantitated by
Northern blotting, as described below. All optical density
values were normalised to that for 0 h.
Hypoxia experiments were performed according to a stan-
dard protocol developed in this laboratory. A431 spheroid
and exponential monolayer cultures were prepared as des-
cribed, and the dishes were placed inside specially designed
aluminum chambers attached to a 5% C02/N2 and vacuum
manifold. Aerobic control cells were incubated for an equal
time period at 5% C02/air at 37°C. The cells in the chambers
were rendered severely hypoxic (less than 10 ppm of ambient
oxygen) at room temperature over about 2 h. After incuba-
tion at 37°C for approximately 15 h, the chambers were
opened, the dishes were placed on ice, and the spheroid
cultures were pooled and centrifuged at 228 g at 4°C for
3 min. RNA was extracted from the pooled spheroid and
monolayer cultures as described below.
Cell lysis and Northern blotting
For each RNA extraction, spheroids were pooled in a 50 ml
polypropylene centrifuge tube and centrifuged at 228 g for
3 min. During this time, the medium was aspirated from the
monolayer dishes and a total of 3.5 ml of lysis solution,
composed of 4 M guanidinium isothiocyanate, 20 mM sodium
acetate (pH 5.2), 0.1 mM DTT and 0.5% N-laurylsarcosine,
was added to all of the dishes. The lysate was pipetted into a
15 ml polypropylene centrifuge tube, and the sample was
immediately frozen in an ethanol/dry ice slush bath. For
extraction of RNA from the spheroids, the supernatant was
aspirated from the spheroid pellet, 3.5 ml of lysis solution
was added and the sample was placed in the slush bath.
Samples were stored at - 80°C until the RNA extraction was
performed.
For the preparation of total RNA for Northern blotting,
each lysate was layered on top of 1.5 ml of 5.7 M CsCl in an
autoclaved polyallomer ultracentrifuge tube (Beckman Instru-
ments, Inc., Palo Alto, CA). The CsCl step gradients were
centrifuged at 35,000 r.p.m. in a Beckman SW 50.1 rotor for
16 h at 18°C. The RNA pellets were dissolved in 400 gIl of TE
buffer, ethanol-precipitated, redissolved in 100 gil of RNAase-
free deionised water and stored at - 80°C.
RNA samples were loaded at 15 gig/well in 1% agarose-
denaturing gels containing approximately 0.66 M dissolved
formaldehyde. Electrophoresis was performed at room temp-
erature for approximately 4 h at 100 V in MOPS buffer
consisting for 20 mM 3-(N-morpholino)propanesulfonic acid,
5 mm sodium acetate, and 1 mM EDTA at pH 7.0. Equal
loading of total RNA per well was confirmed by equivalent
ethidium bromide staining of the 28S and 18S rRNA bands.
This procedure was validated by comparing the autoradio-
graphic bands for 28S rRNA obtained by probing memb-
ranes with a 32P-labelled 1.0 kb DNA restriction fragment
containing 28S rRNA sequences. RNA was transferred to
Hybond-C extra nitrocellulose membranes (Amersham, Arling-
ton Heights, IL) and fixed to the membranes by UV cross-
linking using a UV Stratalinker 1800 (Stratagene, La Jolla,
CA). DNA probes were labelled by the random primer tech-
nique using cz-32P-dCTP (Amersham) and the Amersham
Multi-Prime Labeling System. Membranes were prehybri-
dised for 2-4 h and probed (average of 5.8 x 108 c.p.m. pg-l;
x 106 c.p.m. ml-') with a 1.2 kb DNA fragment of human
TGF-o amplified by PCR from a pUC18 plasmid (obtained
from Dr J. Cudlow at the Samuel Lunenfeld Research Insti-
tute, Mount Sinai Hospital, Toronto, Ontario, Canada).
Hybridisations.were performed in 20% formamide for 12 to
16 h at 42°C in a rotary hybridisation incubator (Robbins
Scientific, Sunnyvale, CA). Autoradiographs of the memb-
ranes were produced using Kodak X-AR film and two
Dupont Cronex Plus intensifying screens at -80°C for 24 to
48 h. Densitometry was accomplished using a BVI 4000
image analyser (Biological Vision, Inc., San Mateo, CA).
Immunofluorescence staining of TGF-a on spheroid sections
Suspensions of 6 x 105 A431 cells in 10 ml of 10% DMEM
were plated on 100 mm Lab-Tek dishes (Naperville, IL) con-
taining 10 ml of 2% Bacto Agar (Difco Laboratories,
Detroit, MI) prepared in 10% DMEM. After incubation in
5% CO2 at 37°C for 4 days, the spheroids were collected and
centrifuged at 228 g for 1 min and the pellet was resuspended
in an equal volume of O.C.T. Compound (Miles Inc., Elk-
hart, IN). Droplets having a diameter of less than 5 mm were
frozen on a Teflon platform cooled to -56°C and stored at
-80°C. Cryostat sections were cut to a thickness of 10 ltm,
air dried, and stored at -70°C.
Spheroid sections were fixed for 10 min in acetone at
-20°C and stained for detection of TGF-a by indirect
immunofluorescence using a buffer composed of PBS, 5%
horse serum, 21 tLg ml-' aprotinin (Sigma Chemical Co., St
Louis, MO), 0.5fg ml-' leupeptin (Boehringer-Mannheim,
Indianapolis, IN), and 1 mM phenylmethylsulfonyl fluoride
(PMSF) (Sigma Chemical Co., St Louis, MO). Monoclonal
anti-TGF-ax antibody Ab-2 (Oncogene Science, Inc., Man-
hasset, NY) was added to a concentration of 10jg ml-'. A
horse-antimouse IgG (H + L) antibody (Vector Labs, Burlin-
game, CA), conjugated with fluorescein isothiocyanate
(FITC), was used for fluorescence detection. Immunofluo-
rescence was visualised and photographed with a Zeiss Axio-
skop microscope.
Specificity of the anti-TGF-a antibody was demonstrated
by incubating the antibody with a 10-fold excess (mass/mass)
of recombinant human TGF-a (Collaborative Research, Bed-
ford, MA) overnight at 4°C before staining. Routine controls
were included in which no anti-TGF-a antibody was con-
tained in the staining buffer.
Radioimmunoassay analysisfor TGF-c
Quantitative analysis of TGF-o at the protein level was
accomplished using an RIA kit from Biomedical Technologies
(Stoughton, MA). Monolayer and spheroid cultures were
prepared as described above. For monolayer cultures, A431
cells were plated into 100 mm petri dishes at 1.2 x 106,
6 x 105, and 2 x 105 cells/dish. Spheroid cultures were grown
by plating 1.2 x 106 cells per 100 mm dish. After 4 days of
incubation, the monolayers and spheroids were lysed using a
buffer containing 1 x PBS, 1% Triton X-100, 21 jAgml-'
aprotinin, 1 mM PMSF, 0.5 gig ml-' leupeptin, 10 gg ml-I
DNase, 10 ig ml-' RNAase, and 4.9 mM MgCl2 (biochem-
icals not mentioned previously were obtained from the Sigma
Chemical Co., St Louis, MO). Lysates were centrifuged at
12,000 r.p.m. in a refrigerated microfuge, and the protein
concentrations of the supernatants were determined using a
bicinchoninic acid (BCA) assay (Pierce Chemical Co., Rock-TGF-a SYNTHESIS IN SPHEROIDS 159
ford, IL). The concentrations were adjusted to the lowest
sample concentration (3.371gml-1) and the samples were
stored at -80°C. Average cell densities (cells per square
centimetre) were determined after trypsinisation and counting
of dishes for different plating densities, and total protein
densities (micrograms of total protein per square centimetre)
were calculated.
TGF-o concentrations were determined using triplicate
samples of the lysates. The RIA kit contained human recom-
binant '25I-TGF-x, unlabelled TGF-o for calibration, sheep
antihuman TGF-a antiserum for competitive binding, and
donkey antisheep IgG for immunoprecipitation in the pre-
sence of polyethylene glycol. Five calibration standards were
prepared in duplicate, ranging from 0.2 to 10 ng of TGF-
a ml-'. Values for TGF-o protein were determined as nano-
grams of TGF-a per cell.
Western blotting analysisfor TGF-c
Monolayer and spheroid cultures were prepared and lysed as
described above. For monolayer cultures, A431 cells were
plated into 100 mm petri dishes at 1.3 x 106, 2.0 x 105, and
3.3 x 104 cells/dish. Protein (45 jAg/well) was resolved by one-
dimensional SDS-polyacrylamide gel electrophoresis on 8%
discontinuous gels using a Mighty Small II slab gel apparatus
(Hoeffer Scientific Instruments, San Francisco, CA) and
electroblotted on Immobilon P membranes (Millipore Corp.,
Bedford, MA). TGF-a was detected with a polyclonal sheep-
antiTGF-o antibody (East Acres Biologicals, Southbridge,
MA), a biotinylated polyclonal rabbit-antisheep antibody,
alkaline phosphatase streptavidin (Vector Laboratories, Burl-
ingame, CA), and the substrates NBT and BCIP (BRL,
Gaithersburg, MD). The polyclonal antiTGF-o antibody
recognises epitopes on the mature growth factor.
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Figure 1 TGF-a mRNA levels within day 4 A431 spheroids and
monolayers. a, Ethidium bromide-stained denaturing 1% agarose
gel containing 15fig/lane total RNA from spheroids (lane 1),
exponential monolayers (lane 2), and plateau phase monolayers
(lane 3). Plating densities are described in the Materials and
methods section. The positions of the bands for TGF-a mRNA
(4.5 kb) and the 28S and 18S rRNA are indicated. b, Autoradio-
graph for the Northern blot obtained from the gel shown in a.
Results
Expression ofmRNAfor TGF-c in day 4 A431 spheroid and
monolayer cultures
The ratio of the mRNA level for TGF-o from spheroids to
that from monolayers, as determined by densitometry of
autoradiographs of northern blots, is designated Sp/Mo. The
average value for Sp/Mo for day 4 A431 spheroids and day 4
exponential monolayers is 3.0 ± 0.7 (standard error of the
mean) for six independent experiments. The data points
ranged from extremes of 1.4 to 5.9. A source of indeter-
minate error affecting precision in quantitative studies of
small spheroids is the size distribution within the spheroid
population. Diameters of day 4 A431 spheroids range from
40 to 120 ym, with a mean value of 80 ftm (see Materials and
methods). Similar values for Sp/Mo were obtained using day
4 spheroids and monolayers derived from the CaSki human
squamous carcinoma cell line in which spheroid size distribu-
tion is also a source of error (data not shown).
To determine the effect of monolayer cell density on the
magnitude of Sp/Mo, we performed experiments in which
cells were plated at 2 x 105 and 6 x I05 cells per 100 mm dish
for comparison after 4 days with corresponding spheroid
cultures. A typical autoradiograph of a Northern blot
prepared from a density experiment and probed for TGF-o
message is shown in Figure 1. The value of Sp/Mo is 1.8 for
the lower density monolayer (exponential growth phase) and
2.2 for the higher density monolayer (plateau growth phase);
in this particular experiment, TGF-x message levels are 2 fold
greater in day 4 spheroids compared with those in day 4
monolayers, even at confluency.
Considering the size distribution of day 4 spheroids used in
these experiments, it could be argued that microenvironmen-
tal effects such as oxygen or nutrient deprivation may contri-
bute in some way to the observed differences in amounts of
TGF-a message between the spheroid and monolayer cul-
tures. While this hypothesis is unlikely for spheroids having
diameters smaller than approximately 100 Lm (Sutherland,
1988), an experiment was performed in which day 4 spher-
oids and exponentially growing day 4 monolayers were sub-
jected to severe hypoxic stress for 15 h. An autoradiograph
from the Northern blot obtained for this experiment is shown
in Figure 2. The values of Sp/Mo are 2.7 for the aerobic cells
and 3.1 for the hypoxic cells. This experiment shows that
there was little or no change in the levels of mRNA for
TGF-ac in either the spheroid or monolayer cultures as a
consequence of hypoxic stress. In addition, a 3 fold differ-
ential in relative TGF-a message levels between the two
cultures was maintained on day 5.
Effect ofEGF on TGF-a mRNA in day 4 A431 spheroid and
monolayer cultures
In Figure 3, histograms are shown for the relative values of
TGF-a mRNA levels normalised to time 0 for the corre-
sponding day 4 spheroid and exponential monolayer cultures
exposed to 10 ng ml-' of recombinant murine EGF for up to
2 h. These results combine six independent experiments.
Because the values for subsequent times are presented rela-
tive to the 0 h time point for the same type of culture, they
do not reflect the enhancement of message for spheroids vs
monolayers described above. Within experimental error,
there is no detectable effect on the message levels in the
spheroids but there is a gradual response in the monolayers
such that message levels increase with the length of exposure
to EGF. This response of the A431 monolayer cells to EGF
is in accord with an autocrine induction of TGF-a mRNA
similar to that described for human keratinocytes (Coffey et
al., 1987).
The result obtained for the spheroid cultures would be
predicted, because diffusion studies in this laboratory using
'25I-EGF have demonstrated that penetration by the polypep-
tide depends on concentration, exposure time, and age of the
spheroid. For example, using day 3 spheroids exposed to
lOngml-' EGF, we found that penetration was limited to
a
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Figure 2 TGF-a mRNA levels within A431 spheroids and
monolayers subjected to hypoxic stress on day 4. a, TGF-a
mRNA from hypoxic spheroids (lane 1) and aerobic spheroids
(lane 2); b TGF-a mRNA from hypoxic exponential monolayers
(lane 3) and aerobic exponential monolayers (lane 4) monolayers.
Both hypoxic and aerobic cultures were lysed after approximately
15 h of hypoxic stress. Conditions of loading and electrophoresis
are described in the Materials and methods section.
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Figure 3 Effect of EGF on TGF-ax mRNA in day 4 A431
spheroid and monolayer cultures. Histogram for the relative
levels ofTGF-z mRNA from spheroids a, and exponential mono-
layers b, after the addition of 10ng ml-' or EGF to the cultures
at time 0. Values for each time point are normalised to the time 0
value for the same series. Errors are expressed as standard errors
of the mean.
the outermost cell layers within 2 h and became evenly distri-
buted only by 24 h (Mansbridge et al., submitted to J. Cell
Physiol.). For day 4 A431 spheroids exposed to 10 ng ml-' of
EGF, penetration would probably be limited to the outer-
most cell layer after 2 h.
Figure 4 shows day 4 A431 spheroid sections that display
TGF-x protein by indirect immunofluorescence. The pattern
of immunostaining is uniform and predominantly cytoplas-
mic, and there is no significant distinction between TGF-a
protein expression on the section prepared from a spheroid
not exposed to EGF (a and b) and that from a spheroid
exposed to 1Ongml1 of EGF for 2 h (c and d).
Determination ofTGF-c protein in day 4 spheroid and
monolayer cultures by radioimmunoassay
Figure 5 demonstrates that day 4 spheroid cultures contained
more TGF-o protein per cell than the most densely packed
Figure 4 Indirect immunofluorescence from day 4 A431
spheroid sections exposed to a monoclonal anti-TGF-a antibody.
Preparation of the spheroid sections is described in the Materials
and methods section. All sections were stained in parallel under
identical conditions. The scale bar represents 24 Lm. a, section
from a spheroid stained in the absence of EGF; b, control for a
in which no anti-TGF-a primary antibody was present; c, section
from a spheroid stained after exposure of the original spheroid to
10ngml-I of EGF for 2 h; d, control for c in which no anti-
TGF-a primary antibody was present.
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Figure 5 Determination ofTGF-a protein in day 4 spheroid and
monolayer cultures by radioimmunoassay. Histogram for the
amounts of TGF-a protein expressed as nanograms per cell deter-
mined for spheroids and for monolayers having different densities
on day 4. Plating densities for the monolayer cultures are includ-
ed, and details are given in the Materials and Results section.
Errors are expressed as standard error of the mean.
day 4 monolayers. The corresponding total protein density
value for the spheroids was 6.5 pg of total protein cm-2 (see
Materials and methods). The plating densities for the mono-
layers and the corresponding total protein densities were
2 x 105 cells/dish (25.0tLg total proteincm-2), 6 x 105 cells/
dish (35.5 ig total proteincm-2), and 1.2 x 106 cells/dish
(35.6 ig total proteincm-2). This last plating density pro-
duced the most densely packed confluent monolayers. TGF-a
protein contained within supernatants from the spheroid and
monolayer cultures was below the detection limits of both the
radioimmunoassay and an assay for biological activity based
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Figure 6 Determination of TGF-a protein in day 4 spheroid and
monolayer cultures by Western blotting. Equal amounts of total
protein in cell lysates were loaded in each well in an 8% discon-
tinuous SDS-polyacrylamide gel. Plating densities for the mono-
layer cultures are included, and details are given in the Materials
and methods section. The position of the 18.5 kD molecular
weight marker is shown with an arrow.
on phosphorylation of the EGF-R (data not shown).
Together with the results for levels of mRNA for TGF-a
obtained from the Northern blotting experiments, these data
demonstrate that day 4 spheroids grown from A431 cells
contained greater amounts of the growth factor at both
message and protein levels in comparison with monolayer
cultures.
Determination of TGF-ac protein in day 4 spheroid and
monolayer cultures by Western blotting
Figure 6 shows a Western blot for total protein extracted
from day 4 A431 spheroids and different density monolayers.
The position of an 18.5 kD lysozyme molecular weight stan-
dard (Bio-Rad Laboratories, Richmond, CA) is shown with
an arrow. The positions of the bands for TGF-a are consis-
tent with the molecular weight of human pro-TGF-a (17.5
kD). The figure shows that the relative amount ofpro-TGF-a
in the monolayer cultures decreased with decreasing cell den-
sity and that the spheroids contained the largest relative
amount of the precursor. These data are consistent with the
quantitative differences obtained by radioimmunoassay for
TGF-a protein. We were unable to detect mature TGF-a
(5.5 kD) by Western blotting using this antibody in cell
lysates or in conditioned media from the spheroid and mono-
layer cultures.
Discussion
These results for TGF-x expression at the message and pro-
tein levels in A431 multicellular spheroids underscore the
importance of proximity or cell-cell contact in the synthesis
of TGF-a in a human squamous carcinoma cell line. Small
cell density effects arising from the TGF-a/EGF-R autocrine
loop have been reported in a recent study, but artificial
systems of transfected NIH3T3 cells grown as monolayers
were used (DiMarco et al., 1989). This report demonstrates
that three-dimensional cultures of human squamous carcin-
oma cells can be used to investigate important parameters of
the TGF-a/EGF-R autocrine loop associated with both
ligand and receptor.
Day 4 A431 spheroids showed constitutive expression of
TGF-a mRNA 3 fold greater on the average than that found
in day 4 monolayers in exponential or plateau growth phases.
This relative enhancement of message is unlikely to arise
from diffusion barriers to oxygen or to changes in extracellu-
lar pH within the spheroids, because no effect of prolonged
severe hypoxia on relative message levels was observed
(Figure 2). Depending on the monolayer density chosen for
comparison, within experimental error TGF-a protein was
present at levels 1.3- to 1.9-fold greater on a per-cell basis in
the spheroid cultures (Figure 5). These data suggest that the
positive feedback component of the autocrine loop operates
in A431 spheroid cultures more effectively than in mono-
layers.
A hypothesis to explain the amplified synthesis of TGF-x
in multicellular spheroids can be formulated on the basis of
physical considerations such as cell packing and limited inter-
cellular spaces. Cells in A431 multicellular spheroids are
densely packed, having an average density of 4.2 x 108 cells
cm-3 of tissue (Casiari, 1989). The diffusion characteristics of
tritiated L-glucose indicate a high degree of tortuosity in the
intercellular spaces of A431 and other spheroids (Casiari et
al., 1988). Thus, the secretion of TGF-a into the confined
intercellular spaces within a spheroid is likely to generate
high local concentrations of growth factor among the packed
cells. In the presence of relatively high surface densities of
TGF-a receptors (EGF-R), ligand binding could be diffusion-
limited or could approach this limit (Wiley, 1988). Such an
effective enhancement of EGF-R affinity could cause an in-
creased synthesis of TGF-o mRNA and protein relative to
monolayer cultures through amplification of the positive
feedback loop associated with TGF-a synthesis. Simul-
taneous amplification of a negative feedback loop through
down-regulation of the EGF-R after ligand binding could
establish a relatively high steady state for ligand synthesis
and secretion.
Negative feedback control or attenuation of the EGF-R
response by receptor internalisation in A431 cells has been
reported at high levels of EGF binding (Wiley, 1988).
Previous work in our laboratory has established by Scatchard
analysis that surface expression of the EGF-R on A431 cells
cultured as day 4 spheroids is reduced relative to the number
of surface receptors on the corresponding monolayer cells
(Mansbridge et al., submitted to J. Cell Physiol.). For this
A431 clone, the spheroids have, on the average, 3.4 x 105
± 0.4 x 105 total surface receptors/cell, whereas expontential
monolayers have 22.0 x 105 + 9.3 x 105 total surface recep-
tors/cell. These values represent a down-regulation within the
range of 4- to 8-fold. Ligand binding within spheroids almost
certainly contributes to this receptor down-regulation,
although the process is complex and is influenced by other
factors such as binding affinity and the saturability of endo-
cytosis (Wiley, 1988; Wiley & Cunningham, 1982).
Effects on TGF-a synthesis ofdifferentiation phenoma that
produce subpopulations of cells in A431 spheroid and dense
monolayer cultures may have a causal role in the enhanced
production of TGF-a message and protein. Morphological
indications of epithelial differentiation have been reported for
A431 and CaSki cell monolayers, 14, 21, and 30 day spher-
oids, and tumour xenografts (Kneuchel et al., 1990). How-
ever, we have not observed differences in EGF-R distribution
that can be attributed to cellular heterogeneity within day 4
A431 spheroid sections or in day-4 monolayers by immuno-
fluorescence (data not shown) using the mouse monoclonal
antibody EGFR1 (Amersham, Arlington Heights, IL). This
antibody competes with EGF for binding to the receptor.
Presumably critical subpopulations of cells that may contri-
bute to the enhanced synthesis of TGF-a would be subject to
autocrine effects caused by the relatively high concentrations
of TGF-a present in day 4 spheroids. The relevance of such
subpopulations to TGF-a and EGF-R synthesis will be inves-
tigated.
In spheroids, biologically active, membrane-bound pro-
TGF-a could contribute to the initiation of signal transduc-
tion in adjacent cells through EGF-R activation. Our study
cannot address this issue directly because the Western blott-
ing results for enhanced pro-TGF-a synthesis within spher-
oids compared to monolayers do not permit a discrimination
between cytoplasmic and membrane-bound forms. In addi-
tion, polyclonal antihuman TGF-a antiserum was used in the
radioimmunoassay for detecting TGF-a protein, and thus all
forms of TGF-a present were antigens. However, if memb-
rane-bound pro-TGF-a is biologically active in A431 cells, it
is possible that direct activation of EGF-R signal transduc-
tion by cell-cell contact is an important property of a
spheroid model of the autocrine loop.
In summary, TGF-o synthesis was enhanced at the mes-
sage and protein levels in A431 multicellular spheroids com-
pared with those in A431 monolayers. This result constitutes
an effect of intercellular microenvironments or cell-cell con-
tact on the autoregulation of a growth factor and provides
evidence of the importance of such an effect on the activity
of the TGF-a/EGF-R autocrine loop in a tumour cell line.
We propose that this phenomenon observed in spheroids is a162 K.R. LADEROUTE et al.
more accurate representation of the in vivo situation for
TGF-o synthesis than has been observed in two-dimensional
cultures, and that spheroids can be used to investigate the
autocrine loop. Small multicellular spheroids may be valuable
for the investigation of potential therapeutic agents that are
capable of intercepting autocrine responses.
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